BETH ISRAEL DEACONESS MEDICAL CENTER; INC.;DANA-FARBER CANCER INSTITUTE;DANA-FARBER CANCER INSTITUTE, INC.
发明人:
AVIGAN, DAVID,ROSENBLATT, JACALYN,KUFE, DONALD
申请号：
CA3042945
公开号：
CA3042945A1
申请日:
2017.11.14
申请国别(地区):
CA
年份:
2018
代理人:
摘要：
The present invention provides compositions and methods for treating cancer, wherein the composition comprises: a. a population a cells comprising a dendritic cell/tumor cell fusion or a dendritic cell/extracellular vesicle fusion； and b. an indoleamine-2,3-dioxygenase (IDO) inhibitor and/or a hypomethylating agent (HMA).
